kabutan

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.(2395) Summary

2395
TSE Prime
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
1,885
JPY
-67
(-3.43%)
Dec 12, 3:30 pm JST
12.09
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
1,894.5
Dec 12, 9:49 pm JST
Summary Chart Historical News Financial Result
PER
22.1
PBR
2.07
Yield
2.65%
Margin Trading Ratio
5.83
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
1,960 JPY 12.60 USD
Previous Close Dec 11
1,952 JPY 12.50 USD
High Dec 12, 9:02 am
1,977 JPY 12.70 USD
Low Dec 12, 2:44 pm
1,880 JPY 12.07 USD
Volume
298,900
Trading Value
0.57B JPY 3.68M USD
VWAP
1917.07 JPY 12.3 USD
Minimum Trading Value
188,500 JPY 1,209 USD
Market Cap
0.08T JPY 0.51B USD
Number of Trades
1,129
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
Slightly High
1-Year Average
930
1-Year High May 1, 2025
5,267
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 56,600 734,100 12.97
Nov 28, 2025 56,400 714,800 12.67
Nov 21, 2025 36,400 804,900 22.11
Nov 14, 2025 15,900 866,800 54.52
Nov 7, 2025 29,400 925,500 31.48
Company Profile
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is the domestic leader in preclinical testing services. The company offers services from basic research to contract testing, with a focus on pharmaceutical formulations. It is also involved in regenerative medicine.
Sector
Services
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. primarily operates in the CRO (Contract Research Organization) business, supporting pharmaceutical development. The company also engages in translational research, leveraging its proprietary nasal drug delivery technology and nurturing basic knowledge and technologies from universities and biotech ventures into viable businesses. Additionally, as part of its Medipolis project (a social benefit creation initiative), the company operates geothermal power generation and accommodation facilities utilizing its property in Ibusuki City, Kagoshima Prefecture.